STOCKHOLDERS’ EQUITY

Changes in Accumulated Other Comprehensive Income (Loss)

The table below presents changes in AOCI by component for the three and nine months ended September 30, 2017 and 2016. All amounts are net of tax (in millions).



	Three Months Ended September 30, 2017														Three Months Ended September 30, 2016
	CTA			Derivative Hedging Adj.			Debt & Equity Securities Adj.		Pension Liability Adj.			Total			CTA			Derivative Hedging Adj.			Debt & Equity Securities Adj.			Pension Liability Adj.			Total
Beginning balance	$	(190.3	)	$	3.1		$	1.3	$	(107.7	)	$	(293.6	)	$	(503.2	)	$	(2.5	)	$	(4.0	)	$	(146.6	)	$	(656.3	)
Other comprehensive income (loss) before reclassifications	32.4			(0.1		)	2.4		(2.0		)	32.7			2.1			(1.1		)	(1.2		)	—			(0.2		)
Amounts reclassified from AOCI	(1.2		)	(1.0		)	—		1.5			(0.7		)	0.1			0.9			—			1.7			2.7
Net Other Comprehensive Income (Loss)	31.2			(1.1		)	2.4		(0.5		)	32.0			2.2			(0.2		)	(1.2		)	1.7			2.5
Ending balance	$	(159.1	)	$	2.0		$	3.7	$	(108.2	)	$	(261.6	)	$	(501.0	)	$	(2.7	)	$	(5.2	)	$	(144.9	)	$	(653.8	)



	Nine Months Ended September 30, 2017														Nine Months Ended September 30, 2016
	CTA (1)			Derivative Hedging Adj.			Debt & Equity Securities Adj.		Pension Liability Adj. (2)			Total			CTA			Derivative Hedging Adj.			Debt & Equity Securities Adj.			Pension Liability Adj.			Total
Beginning balance	$	(615.3	)	$	(2.4	)	$	0.6	$	(162.3	)	$	(779.4	)	$	(492.7	)	$	2.3		$	(6.3	)	$	(152.9	)	$	(649.6	)
Other comprehensive income (loss) before reclassifications	100.4			3.7			3.0		(5.5		)	101.6			(8.4		)	(4.7		)	1.1			3.0			(9.0		)
Amounts reclassified from AOCI	355.8			0.7			0.1		59.6			416.2			0.1			(0.3		)	—			5.0			4.8
Net Other Comprehensive Income (Loss)	456.2			4.4			3.1		54.1			517.8			(8.3		)	(5.0		)	1.1			8.0			(4.2		)
Ending balance	$	(159.1	)	$	2.0		$	3.7	$	(108.2	)	$	(261.6	)	$	(501.0	)	$	(2.7	)	$	(5.2	)	$	(144.9	)	$	(653.8	)

(1) Reclassification of $352.1 million of losses (net of $1.5 million of tax benefits) from AOCI to Gain (loss) on disposition of discontinued operations - net of tax in connection with the sale of the MHPS business during the nine months ended September 30, 2017.

(2) Reclassification of AOCI during the nine months ended September 30, 2017 primarily relates to $55.4 million of losses (net of $23.9 million of tax benefits) reclassified from AOCI to Gain (loss) on disposition of discontinued operations - net of tax in connection with the sale of the MHPS business.

Noncontrolling Interest

During the nine months ended September 30, 2017, Noncontrolling interest decreased by $35.9 million primarily due to the divestiture of our MHPS segment in January of 2017.

Stock-Based Compensation

During the nine months ended September 30, 2017, the Company awarded 1.4 million shares of restricted stock to its employees with a weighted average grant date fair value of $32.34 per share. Approximately 63% of these restricted stock awards vest ratably over a three year period and approximately 37% cliff vest at the end of a three year period. Approximately 13% of the shares granted are based on performance targets containing a market condition determined over a three year period. The Company used the Monte Carlo method to determine grant date fair value of $36.48 per share for the awards with a market condition granted on March 2, 2017. The Monte Carlo method is a statistical simulation technique used to provide the grant date fair value of an award. The following table presents the weighted-average assumptions used in the valuation:



	Grant date
	March 2, 2017
Dividend yields	1.01	%
Expected volatility	42.78	%
Risk free interest rate	1.55	%
Expected life (in years)	3

Share Repurchases and Dividends

In February 2015, the Company announced authorization by its Board of Directors for the repurchase of up to $200 million of the Company’s outstanding shares of common stock of which approximately $131 million of this authorization was utilized prior to January 1, 2017. In February 2017, the Company announced authorization by its Board of Directors for the repurchase of up to an additional $350 million of the Company’s outstanding shares of common stock. In May 2017, the Company announced the completion of the February 2015 and February 2017 authorizations and subsequently that the Company’s Board of Directors had authorized the repurchase of up to an additional $280 million of the Company’s outstanding shares of common stock. In September 2017, the Company announced the completion of the May 2017 authorization and subsequently that the Company’s Board of Directors had authorized a new share repurchase program of up to $225 million of the Company’s outstanding shares of common stock. During the nine months ended September 30, 2017, the Company repurchased approximately 22.3 million shares for approximately $770.2 million under these programs. A portion of the share repurchases was executed prior to September 30, 2017 but cash settled in October. In each of the first three quarters of 2017, the Company’s Board of Directors declared a dividend of $0.08 per share, which was paid to its shareholders. On October 11, 2017 the Company’s Board of Directors declared a quarterly dividend of $0.08 per share, to be paid on December 19, 2017 to all stockholders of record as of the close of business on November 9, 2017.